ASXAGM Date and Closing Date for Director Nominations
other announcement
IXC
Pharmaceuticals, Biotechnology & Life Sciences
Invex Therapeutics
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 1 Oct 2025
- Reported shorts
- 3.5K
- Shares on issue
- 75.154M
Invex Therapeutics (IXC) News
Latest articles and price-sensitive announcements with AI sentiment classification.
Google NewsInvex Therapeutics (ASX: IXC): Can Exenatide’s Alzheimer’s Research Open a New Neurology Pathway? - Kalkine
Invex Therapeutics (ASX: IXC): Can Exenatide’s Alzheimer’s Research Open a New Neurology Pathway? Kalkine
Appendix 4G and Corporate Governance Statement
other announcement
Appendix 4E and Annual Report to shareholders
other announcement
Quarterly Activities/Appendix 4C Cash Flow Report
other announcement
INVEX Therapeutics (ASX:IXC) Shares Rise 10%: What's Behind the Latest Market Interest? - Kalkine
INVEX Therapeutics (ASX:IXC) Shares Rise 10%: What's Behind the Latest Market Interest? Kalkine
Board and Officer Appointments and Company Address Change
other announcement
Resignation of Directors, Co Sec and Cancellation of Meeting
other announcement
Exenatide shows additional positive benefits in brain model
other announcement
Request for extension to voluntary suspension
trading_halt announcement
Notices received under sections 203D(2) and 249D of Corp Act
other announcement
Quarterly Activities/Appendix 4C Cash Flow Report
other announcement
Invex Receives $0.22m R&D Tax Rebate from UK Government
other announcement
Improved Neuronal Cell Survival in 3D Model of Alzheimer's
other announcement
Date of AGM and Closing Date for Director Nominations
other announcement
Quarterly Activities/Appendix 4C Cash Flow Report
other announcement